Treatments

The defining 2026 aesthetics trend is a shift toward inside-out, personalized, regenerative care—where subtle enhancement, whole-body wellness and biocompatible technology work together.
Inside-Out and Innovative: What’s Trending in Aesthetics for 2026
From inside-out radiance to wellness-driven aesthetics, 2026 is shaping up to be the year beauty stops chasing change and starts cultivating longevity.
Featured
The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics
Sponsored
The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics
At ASDS, Allergan Aesthetics convened experts to explore the future of hyaluronic acid fillers—dispelling myths, sharing data and emphasizing education for subtle, natural-looking results.
Dec 3rd, 2025
Dr. Pedram Gerami examines the skin of patient and melanoma survivor Heidi Tarr.
Tanning Beds Triple Melanoma Risk, Potentially Causing Broad DNA Damage
Tanning bed use is tied to almost a threefold increase in melanoma risk, and for the first time, scientists have shown how these devices cause melanoma-linked DNA damage across nearly the entire skin surface, reports a new study led by Northwestern Medicine and University of California, San Francisco.
Dec 17th, 2025
November/December 2025
Read the latest issue

November/December 2025

Read Current IssueSubscribe Now
Top Headlines
Addyi has received FDA approval for use in postmenopausal women, providing a new, non-hormonal treatment option for Hypoactive Sexual Desire Disorder (HSDD).
Postmenopausal Women Can Now Use Addyi for Low Sexual Desire Following FDA Approval
Dec 15th, 2025
The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics
Sponsored
The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics
Dec 3rd, 2025
Medspas achieve greater success by adopting a holistic “inside-out” approach that combines traditional aesthetic treatments with medically supervised wellness services.
Why Modern Medspas Are Adding Wellness—and How to Effectively Integrate and Market These Programs
Dec 10th, 2025
Ptosis is the second most common surgery Eftekhari performs at the Eyelid Center of Utah, after upper eyelid blepharoplasty.
Utah Oculofacial Surgeon to Present Five-Minute Ptosis Surgery at 18th American-Brazilian Aesthetic Meeting
Dec 9th, 2025
Latest
Woman Silhouette In Front Of Window Pregnant Adobe Stock 416615010
Maternal Stress Linked to Early-life Eczema
In a mouse model, elevated levels of corticosterone, a stress hormone, in the amniotic fluid, altered the programming of fetal mast cells and sensory neurons.
Dec 8th, 2025
On Dec. 5, Sculptra was certified in the EU for expanded use on multiple body areas beyond the face.
Sculptra Secures EU Approval for Body Treatments Following Strong Clinical Results
Galderma’s Sculptra has gained EU certification for body use, expanding the collagen-stimulating treatment beyond the face into four new areas.
Dec 5th, 2025
Future Of Aesthetics Report Cover
The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics
At ASDS, Allergan Aesthetics convened experts to explore the future of hyaluronic acid fillers—dispelling myths, sharing data and emphasizing education for subtle, natural-looking results.
Dec 3rd, 2025
The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics
Sponsored
The Future of Hyaluronic Acid Injectable Fillers with Allergan Aesthetics
At ASDS, Allergan Aesthetics convened experts to explore the future of hyaluronic acid fillers—dispelling myths, sharing data and emphasizing education for subtle, natural-looking results.
Dec 3rd, 2025
WHO issues its first global guidelines on GLP-1 therapies, highlighting their potential in treating obesity while stressing that medicine alone isn’t enough.
WHO Publishes First-Ever GLP-1 Obesity Treatment Guideline—Can Our Current Health Systems Keep Up?
WHO’s first-ever GLP-1 recommendations for obesity mark a turning point in global obesity care, while underscoring the world’s lack of readiness.
Dec 1st, 2025
The global aesthetic fillers market is set for steady growth, driven by rising demand for natural-looking results and rapid adoption of innovative hybrid fillers.
Hybrid and Non-Absorbable Fillers Drive Strong Growth in Global Aesthetic Fillers Market
A new market report reveals surprising shifts in consumer demand, regional dynamics and breakthrough filler technologies that are reshaping the multi-billion-dollar aesthetic fillers industry.
Nov 25th, 2025
Laser resurfacing, detox facials and IV therapies offer a way to rejuvenate skin, restore energy and refresh the body for the new year ahead.
Your Post-Holiday Reset: Treatments to Recharge Body and Skin
After the indulgence of the holidays, discover the top treatments, from laser resurfacing to ocean-inspired facials and IV therapies—that help your skin and body feel revitalized for the new year.
Nov 24th, 2025
A new ASA initiative outlines evidence-based guidelines to help people protect and care for their skin throughout life.
National Healthy Skin Month: 7 Essential Habits for Lifelong Skin Health, ASA Identifes
As National Healthy Skin Month unfolds, experts reveal seven lifelong habits that could transform how you care for your skin—at every age.
Nov 21st, 2025
Skin deflation—including collagen loss and shifts in facial volume—is becoming a growing concern for people navigating aging, stress and rapid weight changes, especially those using GLP-1 medications like Ozempic or Wegovy.
Can this Medical-Grade Ingredient Reverse GLP-1 Related Aging?
The popular weight loss drug GLP-1 is aging the skin. The skin care brand Bluelene and Mblue Labs are working on a solution that features a boldly blue medical-grade product.
Nov 21st, 2025
The FDA has reversed its previous decision, making NMN legal again as a dietary supplement and expanding options for those interested in wellness and longevity.
FDA Reinstates NMN for Supplements: Medspas Eye Synergy with NAD+ Therapy and GLP-1 Symptom Relief
The FDA’s reversal on NMN has reopened the door to a potent NAD+ precursor, sparking renewed interest in how it may influence energy, aging and medspa therapies.
Nov 19th, 2025
Tradipitant shows promise in reducing nausea and vomiting caused by GLP-1 weight-loss treatments.
Study Finds Potential Treatment for GLP-1-Induced Nausea and Vomiting
A new study suggests tradipitant could dramatically reduce the nausea and vomiting that often derail GLP-1 weight-loss treatments, potentially changing how patients tolerate these therapies.
Nov 18th, 2025
The FDA-cleared, non-surgical skin tightening treatment is now available for the arms and abdomen, in addition to the face and neck.
Ultherapy Prime Now Cleared for Body: Non-Invasive Skin Tightening Comes to Arms, Abdomen
Ultherapy Prime, long trusted for the face and neck, is now cleared for the body—bringing non-surgical skin tightening to the arms and abdomen.
Nov 5th, 2025